Cargando…
Modest Elevation in BNP in Asymptomatic Hypertensive Patients Reflects Sub-Clinical Cardiac Remodeling, Inflammation and Extracellular Matrix Changes
In asymptomatic subjects B-type natriuretic peptide (BNP) is associated with adverse cardiovascular outcomes even at levels well below contemporary thresholds used for the diagnosis of heart failure. The mechanisms behind these observations are unclear. We examined the hypothesis that in an asymptom...
Autores principales: | Phelan, Dermot, Watson, Chris, Martos, Ramon, Collier, Patrick, Patle, Anil, Donnelly, Seamas, Ledwidge, Mark, Baugh, John, McDonald, Ken |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495762/ https://www.ncbi.nlm.nih.gov/pubmed/23152884 http://dx.doi.org/10.1371/journal.pone.0049259 |
Ejemplares similares
-
Mechanical stretch up-regulates the B-type natriuretic peptide system in human cardiac fibroblasts: a possible defense against transforming growth factor-β mediated fibrosis
por: Watson, Chris J, et al.
Publicado: (2012) -
Atrial Tissue Pro‐Fibrotic M2 Macrophage Marker CD163+, Gene Expression of Procollagen and B‐Type Natriuretic Peptide
por: Watson, Chris J., et al.
Publicado: (2020) -
Comparison of longitudinal change in sST2 vs BNP to predict major adverse cardiovascular events in asymptomatic patients in the community
por: Watson, Chris J., et al.
Publicado: (2020) -
NT‐proBNP/BNP ratio for prognostication in European Caucasian patients enrolled in a heart failure prevention programme
por: Sweeney, Claire, et al.
Publicado: (2021) -
STOP-HF Trial: Higher Endogenous BNP and Cardiovascular Protection in Subjects at Risk for Heart Failure
por: Cannone, Valentina, et al.
Publicado: (2021)